| SCHRODER ISF TAIWANESE EQUITY A ACC USD | RVI CHINA | 22,54% | 68,02% | 71,75% | 267,83% |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | BIOTECNOLOGÍA | 23,46% | 60,54% | 74,94% | 267,40% |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND A USD HEDGED | RVI JAPÓN VALOR | 29,20% | 126,98% | 221,19% | 267,26% |
| NEUBERGER BERMAN US MULTI CAP OPPORTUNITIES ZAR E ACC (HEDGED) | RVI USA | 17,55% | 55,04% | 72,03% | 267,17% |
| NEUBERGER BERMAN US MULTI CAP OPPORTUNITIES ZAR B ACC (HEDGED) | RVI USA | 17,56% | 55,05% | 72,03% | 267,14% |
| AB SICAV I-SELECT US EQUITY PORTFOLIO I EUR | RVI USA | 5,87% | 64,02% | 105,11% | 267,09% |
| JANUS HENDERSON US FORTY H2 EUR HEDGED | RVI USA CRECIMIENTO | 15,33% | 97,05% | 55,98% | 266,64% |
| AXA WORLD FUNDS-US RESPONSIBLE GROWTH A CAP USD | RVI USA CRECIMIENTO | -4,35% | 59,35% | 66,45% | 266,47% |
| AB SICAV I-SUSTAINABLE US THEMATIC PORTFOLIO S USD | RVI USA | -5,07% | 32,68% | 43,87% | 266,40% |
| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | BIOTECNOLOGÍA | 23,57% | 61,14% | 74,96% | 266,35% |
| GOLDMAN SACHS US ENHANCED EQUITY I CAP EUR | RVI USA | 3,03% | 72,08% | 102,49% | 266,12% |
| AMUNDI MSCI NORTH AMERICA ESG BROAD TRANSITION IE CAP | RVI USA | 3,72% | 65,10% | 90,59% | 265,61% |
| PRIVILEDGE - ALPHA JAPAN (EUR) N CAP SYST. HDG | RVI JAPÓN | 33,18% | 119,97% | 130,64% | 265,30% |
| PICTET - USA INDEX P EUR | RVI USA | 3,73% | 66,75% | 96,00% | 265,25% |
| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO I H EUR CAP | RVI JAPÓN | 21,18% | 100,48% | 88,74% | 265,02% |
| AB SICAV I-SELECT US EQUITY PORTFOLIO I USD | RVI USA | 5,49% | 63,36% | 105,51% | 264,86% |
| GOLDMAN SACHS US ENHANCED EQUITY I CAP USD | RVI USA | 2,88% | 71,35% | 102,39% | 264,63% |
| AMUNDI MSCI NORTH AMERICA ESG BROAD TRANSITION IU CAP | RVI USA | 3,76% | 64,38% | 90,47% | 264,11% |
| PICTET - USA INDEX P USD | RVI USA | 3,51% | 65,92% | 95,77% | 263,50% |
| JPM TAIWAN A (ACC) EUR | RVI CHINA | 21,87% | 79,23% | 71,07% | 263,07% |
